Details of issuance or disposal
Issuance by third-party allotment of the Fifth Series of Stock Acquisition Rights with Exercise Price Adjustment Clauses and issuance of the First Series of Unsecured Corporate Bonds (Private Placement)
Potential shares: 28,000,000 shares (280,000 stock acquisition rights, with each stock acquisition right convertible into 100 shares)
The lower thin line represents the existing number of shares to which these shares will be added.
Stock acquisition rights: ¥4,200,000; corporate bonds: ¥100,000,000
Increase of up to 28,000,000 shares
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance by third-party allotment of the Fifth Series of Stock Acquisition Rights with Exercise Price Adjustment Clauses and issuance of the First Series of Unsecured Corporate Bonds (Private Placement) |
| Number of shares to be issued or disposed of | Potential shares: 28,000,000 shares (280,000 stock acquisition rights, with each stock acquisition right convertible into 100 shares) |
| Issue price and disposal price | ¥15 per stock acquisition right; unit: yen. The bonds will be issued at ¥100 per ¥100 of face value |
| Total issue value | Stock acquisition rights: ¥4,200,000; corporate bonds: ¥100,000,000 |
| Amount of funds to be raised | Total payment amount: ¥3,224.2 million; estimated net proceeds: ¥3,215.921 million |
| Estimated issuance expenses | ¥8.279 million |
| Specific use of funds | Details Redemption of Corporate Bonds / Amount ¥100 million / Scheduled timing of expenditures October 2026, Details Repayment of Borrowings / Amount ¥579 million / Scheduled timing of expenditures October 2026 to December 2026, Details Funds to strengthen the architect proposal business / Amount ¥341 million / Scheduled timing of expenditures November 2026 to February 2030, Details New investment in the environmental-related business / Amount ¥1,161 million / Scheduled timing of expenditures January 2027 to February 2030, Details New investment in overseas and IT businesses / Amount ¥380 million / Scheduled timing of expenditures January 2027 to February 2030, Details Working capital / Amount ¥653 million / Scheduled timing of expenditures November 2026 to February 2030 |
| Payment date | 14 October 2026 (stock acquisition rights); 29 September 2026 (corporate bonds) |
| Intended allottee | Name EVO FUND / Number of Shares Potential shares: 28,000,000 shares |
| Intended allottee's holding policy | For short-term investment purposes. The allottee intends to exercise the stock acquisition rights and sell the shares acquired through the exercise in the market. Any transfer of the stock acquisition rights requires the prior approval of the company's Board of Directors. |
| Total number of issued shares | Increase of up to 28,000,000 shares |
| Basis for determining the amount to be paid | The initial exercise price of the stock acquisition rights is ¥115. After adjustment, it will be 100% of the lowest closing price among the 5 consecutive trading days preceding the adjustment date. The minimum exercise price is ¥58. There is no discount to the reference share price. The bonds will be issued at ¥100 per ¥100 of face value. |
| Exercise price | Initial exercise price: ¥115. Subject to adjustment. Adjusted to 100% of the lowest closing price over 5 consecutive trading days. Minimum price: ¥58. |
| Exercise period | From 15 October 2026 to 17 May 2027 |
| Number of Stock Acquisition Rights | Total issued: 280,000; unexercised balance: Not disclosed |
| Underwriter / lead underwriter | EVOLUTION JAPAN証券株式会社 (EJS) |
| Procedures under the Corporate Code of Conduct | The issuance was deliberated by the Board of Directors and approved unanimously. Whether an opinion was obtained from an independent third party or the shareholders' views were confirmed at a shareholders' meeting is Not disclosed |
| Most recent equity financing | Timing Dated 12 March 2024 / Type Issuance of new shares and stock acquisition rights through a third-party allotment / Amount Not disclosed |
| Impact on Business Performance | The specific impact of this transaction on results for the fiscal year ending February 2027 is Not disclosed. The company aims to secure business continuity and continued listing, and improve its financial base through the financing. |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Because the company has limited cash on hand, the repayment deadlines for its borrowings are approaching, and it needs to address its negative net worth and non-compliance with listing maintenance standards. The funds will be used to strengthen its financial base, repay corporate bonds and borrowings, invest in its architect proposal business, environmental-related business, overseas business and IT business, and secure working capital.